New AI-Powered Blood Test Predicts Early Heart Disease Warning Signs
- Heart Condition Risk Assessment A new AI-powered blood test developed by researchers at the University of Hong Kong can estimate the risk of six major cardiovascular diseases.
- CardiOmicScore leverages machine learning algorithms to identify patterns associated with cardiovascular risk.
- The test’s ability to capture biological changes linked to a person’s current health, lifestyle, and environment sets it apart from static genetic risk scores.
Heart Condition Risk Assessment A new AI-powered blood test developed by researchers at the University of Hong Kong can estimate the risk of six major cardiovascular diseases. The technology, called CardiOmicScore, analyzes thousands of proteins and metabolites to estimate the risk of six major cardiovascular diseases, including heart attack, stroke, heart failure, and atrial fibrillation.
Machine Learning Deciphers Thousands of Biomarkers
CardiOmicScore leverages machine learning algorithms to identify patterns associated with cardiovascular risk. Researchers at the University of Hong Kong developed the tool by analyzing thousands of proteins and metabolites. The system generates a risk score based on the presence and concentration of specific biomarkers, providing a more nuanced assessment than traditional genetic testing.
Dynamic Risk Assessments Beat Static Genetic Tests
The test’s ability to capture biological changes linked to a person’s current health, lifestyle, and environment sets it apart from static genetic risk scores.
High Accuracy, But No Diagnostic Substitute
Hong Kong Pilot Aims to Revolutionize Early Screening
The University of Hong Kong has developed the test to estimate the risk of six major cardiovascular diseases.